Official Title
Study for Clinical Epidemiology and Methods of Diagnosis and Treatment of Novel Coronavirus Pneumonia (NCP)
Brief Summary

To develop practical and effective clinical diagnosis and treatment schemes for the control of novel coronavirus pneumonia.

Detailed Description

By retrospectively analyzing the clinical epidemiological characteristics of the novel coronavirus pneumonia and the current diagnosis and treatment schemes, as well as in-depth analyzing the disease development process and outcome trends of NCP patients to develop practical and effective clinical diagnosis and treatment schemes and provide guarantee for the rapid control of the epidemic.

Recruiting
Novel Coronavirus Pneumonia

Combination Product: systemic treatment
Oxygen therapy, antiviral therapy, antibiotics, hormones, globulin

Eligibility Criteria

Inclusion Criteria:

- Patients confirmed with novel coronavirus pneumonia. The Diagnostic criteria refer to "Pneumonitis Diagnosis and Treatment Scheme for Novel Coronavirus Infection (Trial Version 5)";

Exclusion Criteria:

- Physician judged the patient was not suitable for this clinical trial.

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years~Maximum: 90 Years
Countries
China
Contacts

Yang Jin
13554361146
whunjy@126.com

Jiancai Wu
02785726685

Wuhan Union Hospital, China
NCT Number
MeSH Terms
Coronavirus Infections
Pneumonia